Key result
Ellagic acid improves post-MI hemodynamics and reduces collagen deposition in ovariectomized rats.
Why the study?
Oestrogen deficiency increases oxidative stress and reduces nitric oxide bioavailability, contributing to cardiac fibrosis after MI, prompting investigation into whether ellagic acid attenuates post-MI cardiac fibrosis in ovariectomized rats.
Does ellagic acid improve cardiovascular function and attenuate cardiac fibrosis in ovariectomized rats following myocardial infarction?
Does ellagic acid improve cardiovascular function and attenuate cardiac fibrosis in ovariectomized rats following myocardial infarction?
In a rat model of estrogen deficiency, ellagic acid mitigated post-myocardial infarction cardiac fibrosis and ventricular dysfunction via antioxidant and anti-inflammatory effects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ellagic acid in estrogen-deficient post-MI remodeling; clinical translation remains untested.
Oestrogen deficiency increases oxidative stress and reduces nitric oxide (NO) bioavailability, contributing to cardiac fibrosis following myocardial infarction (MI). This study investigated whether ellagic acid (EA), a natural antioxidant, attenuates post‐MI cardiac fibrosis in ovariectomized rats by reducing oxidative stress and pro‐inflammatory mediators. MI was induced by coronary artery ligation, and EA (30 mg/kg) was administered orally for 4 weeks. Hemodynamic parameters, collagen deposition, infarct size, matrix metalloproteinase‐8 (MMP‐8), NO, superoxide anion and inflammatory cytokines were assessed. MI resulted in ventricular dysfunction, increased collagen deposition and elevated levels of MMP‐8, interleukin‐6 (IL‐6) and superoxide anion. EA treatment improved hemodynamic function, reduced collagen deposition, decreased MMP‐8, IL‐6 and superoxide anion, and enhanced NO bioavailability. These findings demonstrate that EA mitigates cardiac fibrosis and ventricular dysfunction through antioxidant and anti‐inflammatory mechanisms, highlighting its potential as a cardioprotective compound in post‐MI conditions under oestrogen deficiency.
No takes yet. Share an insight, caveat, or question.
Gonçalves et al. (2026) studied Myocardial infarction with oestrogen deficiency. Ellagic acid was evaluated on Hemodynamic parameters, collagen deposition, infarct size, MMP-8, NO, superoxide anion and inflammatory cytokines. Ellagic acid improved hemodynamic function, reduced collagen deposition, decreased MMP-8 and IL-6, and enhanced NO bioavailability in ovariectomized rats following myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: